Human Natural Killer cell-related receptors: diversity, ligands and disease susceptibility.

Natural killer cells patrol the body like security guards, using surface proteins to spot cells that have been hijacked by viruses or turned cancerous. This research programme will map the genetic variations in those proteins across different people, and identify the specific molecules on infected or cancerous cells that the proteins latch onto. The problem is that not everyone responds to infections or tumours in the same way. Some people are more susceptible to certain diseases, and the immune system’s first line of defence—natural killer cells—may hold the key to why. Currently, scientists do not fully understand how variations in these surface proteins affect a person’s ability to recognise threats. If this research succeeds, it could explain why some individuals are prone to particular viral infections or cancers. That knowledge might eventually help doctors predict disease risk or design therapies that boost natural killer cell activity. For now, the work is fundamental science: it aims to answer a basic question about how the immune system distinguishes friend from foe. Past discoveries about immune receptors have led to breakthroughs in immunotherapy, so a deeper understanding of these proteins could open unexpected doors.